Used primarily as an intermediate in pharmaceutical synthesis, this compound plays a key role in the development of drugs targeting gastrointestinal disorders and parasitic infections. Its structure supports the creation of benzimidazole-based active ingredients found in proton pump inhibitors and anthelmintic agents. The silyl protecting group enhances stability during synthesis, allowing selective reactions in multi-step organic pathways. It is especially valuable in research settings for constructing complex molecules where controlled reactivity and functional group compatibility are essential.